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Abstract The cardiovascular effects of inhaled particle matter (PM) are responsible for a substantial morbidity and mortality
attributed to air pollution. Ultrafine particles, like those in diesel exhaust emissions, are a major source of nanopar-
ticles in urban environments, and it is these particles that have the capacity to induce the most significant health
effects. Research has shown that diesel exhaust exposure can have many detrimental effects on the cardiovascular
system both acutely and chronically. This review provides an overview of the cardiovascular effects on PM in air
pollution, with an emphasis on ultrafine particles in vehicle exhaust. We consider the biological mechanisms under-
lying these cardiovascular effects of PM and postulate that cardiovascular dysfunction may be implicated in the
effects of PM in other organ systems. The employment of multiple strategies to tackle air pollution, and especially
ultrafine particles from vehicles, is likely to be accompanied by improvements in cardiovascular health.
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1. Introduction
Public awareness of the health risks of air pollution has never been
higher. Rarely is the subject out of the international media and its pres-
ence looms heavily over regulators and politicians. While we may have
known for many centuries that air pollution is damaging to health, it is
only in last two decades that the full magnitude of the problem has been
recognized. The statistics are staggering. Air pollution is deemed to be
responsible for several million premature deaths worldwide every single
year.1,2 Recent estimates based on further analysis of a modelled air-
borne particle concentration–effect curve have suggested that there
may up to 8.9 million excess deaths per year, specifically from outdoor
air pollution.3 Lifelong exposure to pollution is accompanied by a drastic
shortening of life that varies, on average, from 3 to 6 months in modestly
polluted countries such as the UK and USA, to 1–2 years from the noto-
rious high pollution found in many areas of Sub-Saharan Africa and Asia.4
Ambient (outdoor) air pollution is the 5th biggest risk factor for all-cause
mortality, above more well-recognized risk factors such as low exercise
and poor diet, and the number one environmental risk factor.5 Indeed, it
has been estimated that reducing air pollution to WHO air quality guide-
lines globally would increase life expectancy by 0.6 years; a benefit similar
in magnitude to eradicating lung and breast cancer.4 The morbidity ac-
companying air pollution is great (3.1% of global disability-adjusted life
years), with phenomenal levels of associated economic cost ($1–3 tril-
lion US dollars, per year worldwide).2,6 One of the reasons for these
striking figures is that exposure to air pollution is near ubiquitous. It has
been estimated that >90% of the world’s population lives in areas of
above World Health Organization (WHO) guidelines.7 Levels of many
air pollutants are on the rise in developing countries, but even in devel-
oped nations that have successfully lowered pollutants over the last
50 years, improvements have plateaued, and breeches of regulations in
urban areas are common.
It has long been established that air pollution exacerbates respiratory
conditions such as asthma and chronic pulmonary obstructive disease.
Also, the once-surprising observation that air pollution is associated with
cardiovascular disease is also now well-recognized in the 21st century.
Nonetheless, the cardiovascular effects of pollution should not be dis-
missed. Cardiovascular conditions account for 40–60% of the premature
mortality from air pollution.3,5,8 Additionally, the multifaceted cardiovas-
cular effects represent a substantial burden in their own right as well as
through exacerbation of comorbidities. This review discusses the cardio-
vascular effects of air pollution, focusing on airborne particles and vehicle
emissions as key pollutants of interest. The review is intended as an over-
view of the area (we direct the reader to the following for further
detail9–14) with discussion of the potential role of the cardiovascular sys-
tem in the actions of air pollution in other areas of the body.
2. Constituents of air pollution
There is a plethora of substances in the air that our body is exposed
to and may need to protect against. These include both natural (e.g.
forest fires, volcanic eruptions, aerosolized soil and dusts, pollen, and
moulds) and anthropogenic (e.g. industry, power plants, traffic,
household heating, cooking, construction, mechanical wear, agricul-
ture, etc.) sources. Urban ambient air pollution has received the
most attention due to the high density of urban populations, greater
levels of traffic-derived emissions, and general increasing urbanization
of societies worldwide.
Urban pollution is a complex cocktail of chemicals that can also be
broadly characterized into gases, semi-volatile liquids, and particles.15
Numerous gases are found in urban air, such as sulphur dioxide (SO2),
carbon dioxide (CO2) and monoxide (CO), ozone (O3), and nitrogen di-
oxide (NO2). Several gases in air pollution have oxidative properties, as
well as other means to affect biological systems. Gaseous pollutants have
the potential to cause short- and long-term health effects, possibly in an
additive manner to particulates.9 A diverse array of semi-volatile organic
chemicals form the ‘liquid’ phase of air pollution, including methane, ben-
zene, naphthalene, formaldehyde, polyaromatic hydrocarbons (PAHs),
and alkanes. Semi-volatile chemicals associate or interact with gaseous
and particulate phases of air pollutant. Consequently, distinguishing ex-
posure to levels of individual pollutant constituents and isolating specific
health effects can be challenging.
More consistent associations with health effects (and especially
those of the cardiovascular system) tend to be found for particulate
matter (PM) in the air. Environmental PM tends to be categorized,
measured, and regulated in relation to particle size: coarse particles
(PM10; particles with a diameter of 10lm or less) and fine particles
(PM2.5; diameter of 2.5lm or less) (Figure 1). A third category, ultra-
fine particles (diameter of <100 nm, also termed ‘nanoparticles’), is
believed to be especially important for health, although it is not pos-
sible to measure ultrafine PM using monitoring networks in the envi-
ronment at present. In general, the smaller size fractions exert
greater effects due to their large reactive surface area and their abil-
ity to penetrate deep into the alveoli of the lungs and potentially
into the bloodstream.12
Urban PM has a complex and varied composition. Elemental and or-
ganic carbon form a major part of combustion-derived PM, but non-
carbon constituents such as various mineral dusts, sea salt, ammonium,
nitrates, and sulfates are also present. Additionally, there is a vast array
of chemical species present in urban PM, including organic carbon spe-
cies (PAHs, nitro-PAHs, alkanes, alkenes, alkyl-benzenes, quinones, etc.)
and redox-active transition metals. The availability of these chemicals on
the surface of PM determines a significant proportion of the biological re-
sponse to these particles once they are inhaled. Additionally, particles
may accumulate small amounts of biological material, such as endotoxin,
that are likely to play a role in airway inflammation and other aspects of
the pathophysiological response. Particles in vehicle exhaust have been
the subject of substantial research interest due to high proportion of
ultrafine particles in these emissions (especially so for diesel exhaust;
DE). The composition of combustion-derived nanoparticles, the high
surface area to mass ratio of these smaller particles and their ability to
penetrate deep in the body (see below) all suggest that these particles
may induce a greater relative toxicity of these particles compared to
other sources of PM.
3. Particulate matter and
cardiovascular disease
In 1993, a landmark study in America looked at levels of air pollution in
six difference major US cities over a 14–16-year period.16 They found a
clear relationship whereby higher levels of PM2.5 were associated with
hospital admissions and deaths from cardiovascular disease.
Subsequently, epidemiological studies have shown clear associations
between air pollution and various cardiovascular diseases including coro-
nary artery disease,17–19 cardiac arrhythmia and arrest,20–22 heart
2 M.R. Miller and D.E. Newby
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.failure,23,24 cerebrovascular disease,17,25–29 peripheral arterial dis-
ease,30,31 and venous thromboembolism32 (see9 for further details).
There is evidence that acute exposure is linked to cardiovascular
events. Peters et al.33 showed that individuals presenting with myocardial
infarction were more likely to have been in traffic 1–2 h beforehand.
Although accounting for confounding variables such as noise and stress
is challenging, adjusting for level of exercise did not affect the association.
Subsequent studies34 have confirmed this association, and that it is inde-
pendent of the form of transport used.35
Epidemiological studies have associated air pollution with a number
of endpoints underpinning cardiovascular conditions (Figure 2).
Exposure to urban air pollution is associated with atherosclerosis in a
range of arterial beds.36–38 While there is some inconsistency, PM ex-
posure is also associated with a small (usually <5 mmHg for an inter-
quartile increase in PM2.5), but significant elevation in blood
pressure.39–42 Elevated blood pressure will be partially determined by
constriction or reduced vasodilatation of resistance vessels, which is
evident after exposure to PM.43 Exposure to PM2.5 and traffic (e.g. dis-
tance of residential address from a major road) is also linked to in-
creased arterial stiffness,44–46 although not all studies have found
significant associations.47,48
A number of studies have made use of the non-invasive techniques
to measure heart rate variability (HRV).11,49 There is an overall trend
towards reduction in HRV parameters. Although there is a large de-
gree of inconsistency between parameters and studies,49,50 the HRV
effects associated with PM would be predictive of a worse prognosis
at a population level. The relative ease of measuring HRV has been
exploited in smaller panel studies where it is possible to measure per-
sonal exposure to pollutants (measured by portable devices, instead
of estimates of pollution based on the nearest stationary monitor). In
general, there is a trend towards detrimental HRV changes with PM
exposure.51–55 Use of a facemask to lower exposure to particulate air
pollution can attenuate these changes in HRV.56–58 The findings from
epidemiological studies, results from animal studies (see below), and
preventative effects of beta-blocker therapy,55,59 suggest that PM
alters cardiac rhythm through imbalance of the autonomic nervous
system to decrease the vagal tone and increased sympathetic tone.60
PM exposure also exacerbates cardiac ischaemia, as demonstrated by
ST segment depression.9,61 Beyond HRV, PM2.5 has been linked with
an increase in the incidence of arrhythmia.62 The nature of arrhythmia
depends on the source of pollution, although anthropogenic sources
were primarily responsible.
Figure 1 Different size categories of PM in air pollution. (A) PM10 and PM2.5 are routinely measured in the environment for monitoring and regulation of
air pollution. Ultrafine PM (or nanoparticles: diameter <100 nm) comprise a proportion of urban PM10 and PM2.5, but due to the low mass of ultrafine PM it
is not adequately accounted for by these larger PM metrics. (B) Ultrafine PM has a substantially higher surface area (red highlights) than an equivalent mass of
fine PM. (C) The small size, and unique physicochemical properties, of ultrafine PM in urban environments/vehicle exhaust, engenders these particles with a
higher potential to cause toxicity.
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PM exposure is linked to prothrombotic pathways.63 While there
are inconsistencies between studies looking at markers coagulation
pathways,64–68 this may reflect differences in experimental protocol
and variability in the extent of systemic inflammation occurring simul-
taneous (see below). Overall, there is as tendency for PM to increase
blood fibrinogen, thrombin, von Willebrand factor and platelet
Figure 2 Biological mechanisms linking inhaled particles to cardiovascular morbidity and mortality. Several hypotheses have been proposed for the means
by which inhaled particles have actions on the cardiovascular system. These include: the passage of biological mediators (e.g. not only inflammatory media-
tors but also unidentified mediators that are not traditional cytokines) from the lung into the circulation; activation of alveoli sensory receptors leading to
triggering of neural afferents which can alter the activity of the autonomic nervous system or release of endocrine molecules; direct passage of particles (or
chemicals eluting from particles) into the circulation to directly impair cardiovascular function. We emphasize that there is considerable interplay between
the four pathways shown, with inflammation and oxidative stress, in particular, having the capacity to amply different stages of each pathways. The diagram
also highlights that urban PM exerts many pathophysiological changes on different aspects of the cardiovascular system that ultimately increases cardiovascu-
lar morbidity and mortality.
4 M.R. Miller and D.E. Newby
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activity, and decrease ex vivo coagulation times.63 Fibrinolysis is also
blunted by PM, with decreases in t-PA release and up-regulation of
PAI-1 pathways.63,69
Epidemiology studies have used blood and urine to look for mechanis-
tic markers for the cardiovascular changes. PM or traffic exposure is as-
sociated with several biomarkers of oxidative stress, including oxidation
of plasma proteins and lipids (e.g. malonaldehyde and protein 2-aminoa-
dipic semialdehyde),70,71 urinary isoprostanes,72 and oxidative DNA
adducts (e.g. 8-hydroxy-20-deoxyguanosine).73–76 In many cases, indica-
tions of oxidative stress coincide with markers of inflammation [e.g. C-
reactive protein (CRP), tumour necrosis factor alpha (TNF-a), various
interleukins (IL)], although there is considerable variability in both.9,77
Furthermore, DE particles induce a greater inflammatory response in
individuals with genetic deficiencies in various antioxidant systems.78,79
Recent work in healthy adults80 has also expanded on data from animal
studies81,82 showing that PM2.5 exposure is linked to impaired high-
density lipoprotein function, leading to greater levels of circulating
oxidized low-density lipoprotein (LDL); a key mediator in the early
stages of atherosclerosis.
4. Controlled exposure studies in
human subjects
Controlled exposure studies in healthy volunteers provide a unique op-
portunity to study specific pollutants in isolation or together, and with
the potential to avoid or control many of the confounding variables of
epidemiological studies. These studies have been essential in determining
the mechanisms for the acute biological effects of air pollution in humans
(Figure 2). The majority of studies investigate diesel exhaust (DE) using a
1 or 2 h exposure period, and a dose of DE 100–300lg PM/m3 to
broadly model concentrations found from close proximity to exhaust
emissions in heavy traffic, and representative of those reached in some
international megacities.
Acute exposure to DE has prominent effects on the vasculature.
Using forearm plethsymography, a 1 h exposure of DE impairs the ability
of blood vessels to relax in response to infusions of vasodilator agents.83
The pattern of inhibition between vasodilators suggested an impairment
of endothelial function and the nitric oxide (NO) pathway.83,84 DE also
impairs endothelial responses in the skin microvasculature.85 DE attenu-
ated vascular responses rapidly (within 2 h) and, concerningly, this im-
pairment persisted for at least 24 h after the exposure.86 DE exhaust can
also decrease brachial artery diameter, but not flow-mediated vasodila-
tion, in healthy subjects and those with metabolic syndrome, possibly
through increases in circulating endothelin-1.87 Others have found that,
while DE increase vascular sensitivity to the endothelin pathway, these
changes were more likely to be caused by decreased NO bioavailability
rather that changes in ET-1 levels per se.88 DE can also increase arterial
stiffness89 and raise systolic blood pressure,90 both of which occurred
within 0.5–2 h from the beginning of the exposure.
Controlled exposure to DE alters cardiac function. A notably greater
depression was seen in the ST segment of the ECG in patients with
ischaemic heart disease on exercise, indicating that DE worsened the
cardiac ischaemic stress.91 Acute exposures to DE tend not to be signifi-
cantly associated with alterations in HRV parameters, suggesting that
other constituents in urban air pollution are linked to effects on HRV
that are observed in epidemiological studies.50 Indeed, Devlin et al.92
showed that controlled exposure to concentrated ambient particles
(CAPs) caused changes in HRV and cardiac repolarization in elderly
individuals. A later study from the group showed that ultrafine CAPs had
similar effects in patients with metabolic syndrome who were null for
GSTM1 allele (a prominent antioxidant gene), but not a comparative
group from the general population.93 Likewise, Tong et al.94 showed that
CAPs affected HRV in healthy volunteers, which could be prevented by
taking omega-3 fatty acid supplements.
Using a Badimon system (an ex vivo model of thrombosis using human
blood flowing over a damaged blood vessel), our group demonstrated
that acute exposure to DE promoted blood clotting, the mechanisms of
which included activation of platelets (e.g. increased numbers of platelet-
monocyte aggregates)95 and reduced release of the fibrinolytic factor
tissue-plasminogen activator (t-PA) from the vascular endothelium.83 DE
alters the expression of several antioxidant pathways in peripheral blood
monocytes,96 supporting a role for systemic oxidative stress in the car-
diovascular actions of DE. While controlled exposure to DE does not
appear to be associated with a consistent inflammatory response,97 con-
trolled exposures to CAPs increase blood plasminogen and markers of
acute phase response in individuals with genetic deficiencies in various
antioxidant systems.93
Two studies indicate that particles drive the acute cardiovascular
effects of DE exposure. A retrofit ‘particle trap’ on the engine exhaust ef-
ficiently reduces particle mass in the DE and completely prevented the
thrombotic actions of DE.98 Filtering of particles from DE also prevented
the vascular impairment observed with whole exhaust.99 This observa-
tion was supported by a study100 whereby volunteers were exposed to
pure nitrogen dioxide at concentrations representative of whole ex-
haust; no acute cardiovascular effects were observed. Similarly, ozone
exposure does not have acute cardiovascular effects,101 although co-
exposure of PM and ozone can cause vasoconstriction.102
Particle composition is important to cardiovascular effects of inhaled
PM. Pure carbon particles (i.e. without any surface chemicals present on
diesel exhaust particles) were not associated with cardiovascular
effects.99 Exposure to CAPs from rural environments can also increase
blood pressure in comparison to that to that of filtered air,103 whereas
CAPs that largely consisted of salt (e.g. PM largely arising from maritime
winds) had no effect.104 Finally, both exhaust from idling engines and
engines running in a ‘city cycle’ having detrimental cardiovascular
effects.105
5. Mechanistic studies
There is a substantial body of work ranging from laboratory assays, cell
cultures, isolated tissues, and in vivo studies in animals that build on find-
ings in man to elucidate potential biological mechanisms for the cardio-
vascular effects of air pollution. This section provides a brief overview of
this evidence and we refer readers to other reviews to broaden this
narrative.9–13
Oxidative stress is a key biological mechanism by which diesel exhaust
particles (DEP) exerts actions of the cardiovascular system.77 In the ab-
sence of biological tissue, DEP has the capacity to generate superoxide
free radicals,106 and metals on the surface of DEP can assist in the pro-
duction of hydroxyl free radicals via the Fenton reaction.107,108 Once in
contact with cells, DEP can also trigger oxidative stress via a number of
different cellular mechanisms including NADPH oxidase, xanthine oxi-
dase, uncoupling of NO synthase, and mitochondrial dysfunction.77,109
The lung-lining fluid is rich in antioxidants that will presumably buffer the
pro-oxidative actions of DEP, but particles can clearly overcome this de-
fence to exert systemic oxidative actions.110 Whether inhaled particles
Air pollution and cardiovascular disease 5
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can deplete antioxidant defences with high-dose or prolonged expo-
sures, or if there are processes available by which particles can evade an-
tioxidant defence, has yet to be fully established.
Inflammatory cells within the lung represent a defence mechanism for
inhaled pollutants. Alveolar macrophages actively take up inhaled par-
ticles, as they would biological invaders. However, the physiochemical
properties of combustion-derived PM promote activation of these
cells111 and sufficient doses of PM can induce inflammatory responses
that cause local, and potentially systemic, inflammation. Cell culture stud-
ies demonstrate that while DEP has only modest direct effects on many
cells (unless at very high concentrations), prior interaction with macro-
phages leads to a release of inflammatory mediators that can then induce
marked inflammatory changes in other cells types including endothelial
cells.112 Oxidative stress and inflammation are likely to act synergistically
to amplify each other’s effects. For example, DEP can oxidatively modify
lipids,82 and that DEP and oxidized lipids together have synergistic
actions of the expression profile of pathways linked to vascular inflam-
mation.113 Similarly, the ox-LDL receptor mediates a number of cardio-
vascular effects of vehicle exhaust emissions in atherosclerotic mice,
including infiltration of monocytes and macrophages in the vessel wall.114
While there is potential for inflammation to exacerbate the cardiovascu-
lar effects of inhaled particles in many different respects,115 there is some
doubt as to whether inflammation alone is the underlying cause of these
effects.77
Experiments with isolated tissues have shown that DEP can directly
induce endothelial dysfunction in the absence of inflammatory
cells.43,106,116 Pulmonary exposure to DEP in rodent models in vivo can
induce vascular dysfunction with a similar profile of impairment to that
seen with controlled exposure to DE in man, albeit depending on the
model used and vascular bed studied.43 As well as effects on the pulmo-
nary and peripheral vasculature, animal models have shown that PM has
detrimental effects on the coronary circulation.117–120 PM2.5 can also af-
fect vascular smooth muscle phenotypes, and in vivo exposure increases
the incidence of abdominal aortic aneurysm in angiotensin-II-infused ath-
erosclerotic mice.121
Mouse models of atherosclerosis have been valuable for addressing
the vascular effects of chronic exposure to PM.43 Inhalation of PM pro-
motes early events in atherogenesis, e.g. oxidation of LDL122 and the ad-
herence of leucocytes to the vascular wall.123 Particles such as DEP
increase the burden of atherosclerosis by a range of mechanisms includ-
ing oxidative stress,81,82,113,124–129 changes in arachidonic acid metabo-
lites,82,114,130 endothelin-1 pathways,131 dysfunctional high-density
lipoprotein (HDL),81,132 endothelial nitric oxide synthase (eNOS)
uncoupling,133 and signalling through lectin-like oxidized LDL recep-
tors.114,134 Markers of plaque vulnerability are also increased by
PM,126,128 suggesting that urban PM and DEP exposure could trigger pla-
que rupture. Such observations would support those of epidemiological
studies linking exposure to traffic with hospital admissions for acute
myocardial infarction.
In vivo models have been used to look at the actions of PM on other
facets of the cardiovascular system. Pulmonary exposure of DEP to rats
potentiated the thrombotic occlusion of the carotid artery following ar-
terial injury.135 The response was more notable in response to DEP ex-
posure compared to pure carbon nanoparticles or quartz particles, again
emphasizing the importance of particle composition. Platelet activation
and impaired fibrinolysis were important mechanisms,135 complement-
ing the findings of the clinical exposures to DE.83,95 A range of throm-
botic pathways could contribute to the prothrombotic effects of PM,
including inflammation and oxidative stress,136–138 tissue factor,139
fibrinogen binding,140 impaired fibrinolysis,134,141 and platelets142
(reviewed by Robertson and Miller63).
Farraj et al. have performed detailed preclinical characterization of the
cardiac effects of combustion-derived particles (see143 for a review). As
well as effects in healthy mice, the group have used isoproterenol-
induced models of cardiomyopathy to show that inhalation of various
types of PM promote arrhythmias, alterations in HRV and delays cardiac
conductance.144–146 Long-term exposure to PM promotes myocardial
hypertrophy and loss of cardiac function.147 Pulmonary exposure to
DEP also induced arrhythmia and a greater degree of myocardial infarc-
tion in a rat model of myocardial infarction after coronary ligation.148
Pharmacological inhibition of pulmonary sensory receptors or neural
pathways diminished these effects, demonstrating a role for the neural
systems in the cardiac effects of this air pollutant.148,149 The renin–angio-
tensin system and oxidative stress have also been implicated in the car-
diac effects of PM.150 Direct exposure of cardiac myocytes to DEP can
alter myocardial contractility and calcium handling,151 suggesting that
particle translocation (see below) may be a feasible mechanism account-
ing for the cardiac effects of inhaled PM.
6. From the lung to the
cardiovascular system
The weight of mechanistic evidence provides confidence in the biological
causality for epidemiological associations between PM and CVD. Both
the initial pulmonary response to inhaled PM and the multifaceted nature
of cardiovascular impairment have been well characterized. However,
uncertainty in the biological processes that link inhalation of particles to
that of the cardiovascular system still casts a shadow over the field.
Three main theories have been proposed for the potential linking path-
ways152,153 (Figure 2). The classical hypothesis is that inhaled pollutants
activate inflammatory cells in the lung, leading to the release of inflamma-
tory mediators that pass into the circulation to influence cardiovascular
function.154 There is a convincing case to link together lung inflammation
and cardiovascular disease in general.155 Also, markers of a systemic in-
flammation and oxidative stress are found in the blood after exposure to
PM in blood humans and animal studies.9,156–158 However, there is con-
siderable inconsistency across different biomarkers and between studies,
especially in human subjects, and the time-course of the inflammatory re-
sponse often does not match other systemic effects. Nonetheless, there
is a clear role for both inflammation and oxidative stress in multiple
stages of the mode of action of inhaled PM77,152 and these pathways rep-
resent a key means to amplify the signal from PM112 even if they are not
the critical underlying cause. A convincing argument has also been postu-
lated for acute phase proteins (e.g. CRP or serum amyloid A) in mediat-
ing certain cardiovascular effects.159 Finally, while conventional cytokines
such as TNF-a, IL-6, and CRP do not seem to fully fit the bill, there is
convincing evidence for an, as-yet, unidentified blood-borne mediator
that could bring together the different stages of this pathway.160–162
The second theory is that inhaled pollutants activate alveolar recep-
tors, stimulating sensory afferents that alter cardiovascular function via
changes in autonomic balance or neuroendocrine regulation.143,163,164
The pattern of HRV changes in response to PM would clearly indicate a
shift in the balance of the autonomic nervous system towards reduced
parasympathetic activity and increased sympathetic activity. There is
strong evidence from animal studies showing that pharmacological inhi-
bition of either alveolar sensory receptors or the beta-adrenergic recep-
tors can attenuate the cardiac effects of DEP.148,149 Chemicals species
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on the surface of DEP such as PAHs appear to be key in activating sen-
sory afferents.165 The role of this pathway on non-cardiac aspects of the
cardiovascular system, such as the vasculature and blood, are less certain.
However, the implication of the central nervous system (e.g. the hypo-
thalamus–pituitary–adrenal axis) with subsequent endocrine release into
the blood could fill this gap.164,166,167
The third hypothesis, termed ‘particle translocation’, is that the
nanoparticle fraction of PM is small enough to cross over the lung epi-
thelial barrier and enter the pulmonary circulation, whereby particles
can then be carried in the blood directly to harm other areas of the
cardiovascular system.168 Proving this hypothesis is challenging given
the technical limitations of visualizing these minute particles and
detecting the very low levels of particles once they enter the systemic
circulation. Studies in animals supported this possibility,169–172 but evi-
dence in man was limited. Recently our group used gold nanoparticles
as a model to investigate this pathway.173,174 Following 2 h inhalation
of gold particles (5 nm primary size, median 20 nm particles aggre-
gates in aerosol) in healthy volunteers, gold could be detected in the
blood within 15 min after the exposure, and by 24 h, all volunteers
had measurable levels of gold in both their blood and urine. Gold was
still present in blood and urine on recall of the volunteers 3 months
later, indicating that these particles persist in the body and blood for
very long periods of time. Subsequent studies in animals used a range
of sizes of gold nanoparticles and showed that particles with primary
size of <30 nm, but not larger particles, gained entry to the blood.
Importantly, translocated gold in mice preferentially accumulated in
atherosclerotic arteries compared to arteries without disease.
Furthermore, inhaled gold reached areas of carotid vascular disease in
patients with a history of stroke.173 Recent studies by the laboratories
of Calderon-Garciduenas and Maher175,176 have used advanced elec-
tron microscopy techniques to identify iron-based particles in the
brain and heart177 of cadavers from heavily polluted Mexico City. The
crystal structure and smooth-rounded surface suggests that these par-
ticles derive from combustion processes. While there are still some
uncertainties as to whether these are inhaled particles, or that carbon-
based particles also behave in the same way, these meticulous studies
provide compelling evidence that exogenous particles can penetrate
several organs of the body. Additionally, it is notable that the particles
identified were associated with cellular damage, reinforcing the con-
cept that particle translocation directly contributes to pathophysiologi-
cal injury. Whether or not sufficient particle numbers translocate to
induce cardiovascular effects is open for debate. However, the ability
of DEP to generate free radicals, activate inflammatory cells, and di-
rectly impair vascular and cardiac function, suggests that should PM
such as DEP also translocate in a similar manner to the gold nanopar-
ticles, then these particles can promote cardiovascular disease.
7. Role of the cardiovascular system
in the systemic effects of air
pollution
In light of the many biological mechanisms by which PM can promote dis-
ease, it is logical that exposure will be associated with a range of extra-
pulmonary effects.178 Nonetheless, the diversity of these effects is
somewhat alarming (Figure 3). These include exacerbation of metabolic
syndrome and diabetes,42,179–181 chronic kidney disease,182,183 various
cancers,184–187 inflammatory bowel disease,188 osteoporosis,189 and liver
disease.190 PM exposure alters circulating stem cell populations191,192
and may promote rejection of organ transplants.193 Air pollution has
also been linked to skin diseases,194 autoimmune diseases,195 and
infertility.196
Research into air pollution on the central nervous system has discov-
ered links between air pollution and impaired cognition,197–199 demen-
tia200–202 and even antisocial behaviour,203 and teenage psychosis.204
There is substantial attention on the early life effects of air pollution
where maternal exposure has been linked to poor birth outcomes
(e.g. preterm birth, low birth weight, stillbirth, or spontaneous
abortion),205–207 congenital defects,208 and ill health of the children later
in life.209 Furthermore, early childhood exposure has been linked to
effects on asthma,210 lung development,211 childhood leukaemia,212
obesity,213 attention disorders,214 and autism.215
While the range of possible harmful effects of air pollution across the
body is disturbing, our growing understanding of the mechanisms of air
pollutions goes some way to explaining these observations. Oxidative
stress and inflammation are ubiquitous pathways in most diseases, and
characteristically amplify each other’s molecular pathophysiology. While,
the nature of the mechanism that ‘carries’ this ‘signal’ from the lung to
other organs still requires elucidation, nanoparticle translocation, and
neuroendocrine pathways could also bridge this gap. Additionally, sev-
eral systemic effects of air pollution may be indirectly caused, or at least
exacerbated, by the impairments in cardiovascular function caused by in-
haled PM (Figure 4).
Widespread vascular dysfunction would be expected to be accompa-
nied by raised blood pressure; a recognized risk factor for multiple mor-
bidities beyond the cardiovascular system. Similarly, impaired circulatory
control could result in inadequate perfusion of organs and potentially
ischaemic damage when combined with an increased propensity for
thromboembolism. In particular, the risk factors for diabetes are intri-
cately linked to those of cardiovascular disease, with pathophysiology of
the multiple vascular beds commonly developing with progression of
Type 2 diabetes mellitus. Endothelial dysfunction usual precedes insulin
resistance, and the dual vascular and proinflammatory effect of PM on
both glucose homoeostasis179 and impairment of cardiovascular function
will contribute to the co-morbidity. Indeed, animal studies show syner-
gism between air pollution and hypercholesterolaemia, promoting insu-
lin resistance, enlargement of fat beds, and inflammation of visceral
adipose tissue, in addition to endothelial dysfunction180,181 and develop-
ment of atherosclerosis.216
Research into the effect of air pollution on the kidney is in its infancy.
However, PM2.5 has been linked to membranous nephropathy, decline
in renal function and increased incidence of end-stage renal disease.183
Many of the cardiovascular actions of PM could exacerbate the patho-
physiology of kidney disease through elevated blood pressure, impaired
renal perfusion, or inflammation. Indeed, administration of DEP to a rat
model of adenine-induced chronic kidney disease decreased renal blood
flow, in addition to increasing systemic blood pressure.182 Work with dif-
ferent sized gold nanoparticles suggests that some particles be small
enough to pass from the lung to the blood, but not be small enough to
pass through the filtering mechanisms of the kidney.173 Theoretically, ac-
cumulation of particles in the kidney would be expected to promote in-
flammation and oxidative stress and predispose other disease processes
in the kidney.
It is reasonable to assume that the vascular effects of air pollution seen
in many other areas of the body will be relevant to the brain. Given that
approximately a third of stroke survivors would be expected to develop
dementia within 5 years,217 the established link between air pollution
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(notably PM) and stroke26,29,218 would also be expected to extend to
cognitive impairment and dementias linked to circulatory causes.
Atherosclerosis (both in the carotid and cerebral arteries), increased
thrombogenicity and loss of vascular flexibility are plausible cardiovascu-
lar mechanisms by which PM could induce ischaemic and haemorrhagic
stroke, respectively. In this regard, PM is associated with increases in
carotid-intima thickness9,37,219 and extensive carotid atheroma can have
clinical manifestations linked to cerebral ischaemia or embolism.
Increased endothelin-1220 and angiotensin-II221 concentrations are ob-
served in the cerebral cortex in Alzheimer’s disease, and build-up of
these vasoconstrictors may contribute to the impairments in blood flow
within the brain. Addressing the effects of PM on cerebral vasculature in
man is more challenging, although Wellenius et al.222 used transcranial
Doppler ultrasound to look at non-structural changes in blood flow in
the middle cerebral artery in elderly human subjects. An 8% increase
in vascular resistance was observed per interquartile (3lg/m3) increase
in PM2.5.
222 Polymorphisms in apolipoprotein E alleles are the most
prevalent genetic risk factor for Alzheimer’s disease, with carriers of the
E4 allele experiencing accelerated cognitive decline and neurodegenera-
tion.223 However, apoE4 is also intrinsically linked to insulin resistance,
microvascular integrity (including the blood–brain barrier) and athero-
sclerosis. Indeed ApoE4 is important in both the control of LDL-
cholesterol in the blood and for clearance of amyloid-beta from the
brain, the accumulation of which is a hallmark of several forms of demen-
tia. Thus it is interesting that carriers of the APOE4 allele also have
greater susceptibility to the effects of air pollution than non-carriers, in
terms of cognition224–226 and indicators of metabolic syndrome.223,227
The effects of air pollution during pregnancy are a highly active area of
research, and again there is a case for the cardiovascular effects of PM to
play a role. Pre-eclampsia and other hypertensive disorders during preg-
nancy occur in10% of pregnancies. These conditions have a substantial
health burden, potentially leading to seizures, long-term disabilities, and
maternal or perinatal mortality.228 The effects of exposure to air pollu-
tion on systemic blood pressure are relatively small and it is unclear
whether such effect would have a significant contribution to pre-
eclampsia. Nonetheless, research has suggested that in the region of 8%
of hypertensive disorders during pregnancy we attributable to exposure
to PM2.5 (based on >9lg/m
3 PM2.5 exposure throughout the entire
pregnancy).229 While a systemic endothelial dysfunction would be a
likely mechanism by which PM could contribute to pre-eclampsia, PM
exerts specific effects on the foetal-placental circulation. Exposure to
ambient PM (close to roadside in Sao Paulo, Brazil) during pregnancy
changes the structural integrity of the umbilical cord in mice.230
Gestational exposure to diesel exhaust decreases placental blood flow
and foetal capillary numbers in rabbits.231 DE can also induce haemor-
rhage and compaction of the labyrinth vascular spaces in mice.232
Figure 3 Emerging evidence showing that air pollution has effects throughout the body. Over the last few decades it has become apparent that air pollu-
tion can effects beyond the pulmonary and cardiovascular system. This schematic highlights a number of examples of extrapulmonary effects of air pollution
in general, although in most cases there is strong evidence for a role of particulates specifically. COPD, chronic obstructive pulmonary disease; HDL, high-
density lipoprotein.
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Furthermore, an early report makes claims to have found suspect PM in
the placenta of non-smoking mothers living in polluted areas233 and
there are some indications from rodent studies that blood-borne (non-
environmental model) nanoparticles may reach the foetus.234,235 It is
also plausible that translocated particles could induce a localized inflam-
mation and oxidative stress within the placenta, that induces chronic vas-
cular remodelling and potentially increases in vascular permeability that
could aid the passage of particles to the unborn child.
Finally, the vascular effects of certain pollutants may also play a role in
tumour growth. The International Agency for Research on Cancer
(IARC) classified diesel exhaust as a Class 1 carcinogen in 2012 based on
the combined evidence from studies in miners, animal data, and the po-
tential for DEP to cause genotoxicity in vitro.236 However, while there is
a clear case for setting occupational exposure limits to diesel exhaust,
extrapolation to risk for the general public is challenging.237
Nonetheless, given the prevalence of diesel particles at roadsides (mea-
sured as elemental carbon) and lifetime exposure, researchers have pos-
tulated that this pollutant will contribute to the incidence of cancer in
the general public.238 Interestingly, a study by Xu et al.239 investigated the
influence of DEP on angiogenesis, with regard to the role that blood ves-
sel formation plays in tumour formation. The investigators showed that
inhalation of diesel exhaust led to increased growth of new blood vessels
in hypoxic tissues in mice, while decreasing eNOS expression and in-
creasing inflammatory cell penetration. It should be noted that the con-
centrations of DE used in the study were high (1 mg PM/m3) for a
prolonged period to time (2–8 weeks). Furthermore, artificial in vivo
Figure 4 Biological mechanisms by which inhaled particles can impair the cardiovascular system and affect other organs in the body. (A) Several mecha-
nisms have the potential to account for the ability of inhaled particles to induce cardiovascular actions: Inhaled particles stimulate sensory receptors in the
lung, leading to changes in neural activity and endocrine release; small nanoparticles may pass (‘translocate’) into the circulation and directly act on the car-
diovascular system; Induction of lung inflammation may result in a ‘spill-over’ of inflammatory mediators into the systemic circulation; other, as-yet unidenti-
fied, blood-borne mediators may drive the cardiovascular effects of inhaled particles. (B) The mechanisms proposed to account for the cardiovascular
actions of inhaled particles could also be responsible for a range of effects in other organs of the body. (C) Various impairments in cardiovascular function
could also indirectly contribute to the action of inhaled particles in other organs of the body.
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models of ischaemia were employed as a trigger for angiogenesis,
whereas in other scenarios new blood vessel formation could be viewed
as a beneficial response to improve blood supply to ischaemic regions.
Therefore, while it remains to be established whether this process
would contribute to the growth and development of tumours, the
observations are intriguing nonetheless, and expand further on the
growing list of cardiovascular effects of vehicle exhaust.
8. Conclusions and implications
The cardiovascular effects of ambient PM make an extensive contribu-
tion to the substantial burden of air pollution on health. Epidemiological
studies have found sizeable (and largely consistent) associations between
exposure to urban PM and cardiovascular mortality and morbidities, in-
cluding myocardial infarction and stroke. Furthermore, exposure to PM
has both acute (e.g. alterations in heart rate and increased blood pres-
sure) and chronic (e.g. exacerbation of atherosclerosis) actions on the
cardiovascular system. Pollutants such as diesel exhaust particles can ex-
ert a multitude of effects on different facets of the cardiovascular system.
These include vascular dysfunction, increased susceptibility of the heart
to ischaemic damage, and an increased propensity for thrombosis. An ar-
ray of different biological pathways appears to underlie the cardiovascu-
lar actions of inhaled PM. Oxidative stress and inflammation remain key
pathways by which inhaled PM may cause harm to the body, although
the ability of these nanoparticle fractions of PM to translocate into the
circulation could also account for the widespread effects of PM around
the body. Translocation appears to be largely restricted to the smallest
nanoparticles, and it is feasible that this could include a proportion of the
particulates found in vehicle emissions such as diesel exhaust. Given the
large reactive surface area of these particles, their recognized toxicity,
and the potential harm from co-pollutants such as nitrogen dioxide, it is
clear that reducing emissions from vehicles should be a priority for air
quality strategies.
There are clear socioeconomic inequalities of air pollution exposure,
both in terms of exposure to pollutants (low-cost housing is often in the
areas of highest pollution) and associations with other risk factors for dis-
ease (deprivation is linked to poor diet, inactivity, and, often, greater lev-
els of smoking, alcohol, and drug use). As well as the overlap and
interactions between these risk factors, the impaired cardiovascular
function associated with air pollution will further compound health.
Raised blood pressure, propensity for thromboembolism, and cardiac in-
efficiency will, in themselves, be risk factors for co-morbidities. In addi-
tion to this, from a pathophysiological perspective, there are a number
of means by which cardiovascular dysfunction linked to PM exposure
may indirect contribute to effect in other organ systems. These include
links to cardiovascular complications of metabolic disease and diabetes,
stroke and vascular dementia, changes to circulatory system of the pla-
centa in pregnancy, and potentially vascularization of tumours. To what
extent the cardiovascular system contributes to these conditions
remains to be determined. However, these possibilities further
emphasize the widespread effects of air pollution throughout the body.
Practically, they also suggest that interventions that reduce air pollution
could lead to beneficial effects on multiple organ systems.
While significant improvements in air quality have been made in many
countries, air pollution is increasing beyond the already extreme levels
frequently found in many developing nations. Furthermore, there are
clear differences in guidelines for different limit levels of pollutants in dif-
ferent nations (e.g. WHO recommended annual PM2.5: <10lg/m
3; USA:
<12lg/m3; Europe: <25lg/m3; and China: <35lg/m3). Furthermore,
based on the current data available, there is no recognized level of air
pollution that is considered ‘safe’. Certainly, robust studies have shown
that levels of PM and air pollution below stringent guidelines (e.g. WHO,
PM2.5 <10lg/m
3) are still associated with significant health effects.129,240
It is clear that air pollution is global concern that should not be met with
complacency.
A combination of strategies should be used to reduce air pollution ef-
fectively. Indeed, a recent examination of the potential interventions in
the UK has identified a number of strategies by which different sectors
can tackle air pollution.241 However, the report emphasizes that a con-
certed implementation of measures is required to realize gains in air
quality that are unlikely to be possible from isolated interventions. In
terms of pollutants, from a cardiovascular perspective alone, reducing
PM should be a priority. Epidemiological assessments of cities that have
successfully decreased particulate air pollution levels have reduced car-
diovascular mortality.42 Indeed, it is encouraging that a number of studies
have shown that reduction of personal exposure to urban PM through
use of facemasks has been accompanied by improvements in cardiovas-
cular parameters.42,56–58,242 Indoor air purifiers also appear to have ben-
eficial effects in this regard, especially in cities with high levels of
pollution.42,243 The long-term consequences of these short-term bene-
fits need to be established.
The mass metrics of PM10 and PM2.5 are not ideal for quantifying ultra-
fine particles from vehicle exhaust.244 Given the strong mechanistic evi-
dence for the scale of harm that combustion-derived particles exert on
the cardiovascular system, targeting PM from vehicle emissions may well
be accompanied by improvements in cardiovascular health beyond that
which would be estimated from reductions in PM10 and PM2.5.
Experimental studies in man have already shown that removal of particu-
lates from diesel exhaust can prevent the acute cardiovascular parame-
ters associated with this pollutant.98,99 Rodent studies have also shown
the potential for fuel additives that reduce particle numbers in tailpipe
emissions to prevent the pro-atherosclerotic effects of DEP.245 Modern
combustion engines are substantially more efficient, with Euro 6 diesel
engine emitting, on average, 10 less PM than a Euro 3 engine (albeit
these are based on mass metrics from Euro emission standards for regu-
lated diesel vehicles—emissions vary considerably with the type of vehi-
cle and the situation is considerably more complicated and variable
under real-world driving conditions).246 Furthermore, the rapid rise in
popularity of electric vehicle (and improvements in charging infrastruc-
ture, battery efficiency, and the electrification of commercial vehicles)
suggests that the eradication of combustion-derived particles from
vehicles may be achievable. And if this aspiration can be realized, signifi-
cant improvements in cardiovascular health will likely follow.
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